1) Pirmagrel
吡吗格雷
2) clopidogre
氯吡格雷
1.
Effect of combination of clopidogre with aspirin on platelet activation in elderly patients with unstable angina pectoris;
氯吡格雷联合阿司匹林对老年不稳定型心绞痛患者血小板活化的临床干预研究
2.
Clincial study on the therapeutic effcts of Clopidogre and GM1 on progessive cerebral infarction;
氯吡格雷联合脑苷肌肽治疗进展型脑梗死临床研究(附52例报告)
3.
Study on the Effects of Clopidogre and Aspirin Application into the Patients with Coronary Heart Disease;
氯吡格雷与阿司匹林应用于高龄老年冠心病患者的临床作用比较
3) Clopisogrel sulfate
氟吡格雷
1.
Objective To evaluate the clinical effect of lescol in combination with low molecular weight heparin and Clopisogrel sulfate in treating patients with unstable angina.
治疗组患者在常规治疗的基础上加用氟伐他汀(商品名:来适可)40mg,1次/晚;低分子肝素5000U腹壁皮下注射,1次/12h,连用7d;氟吡格雷75mg,1次/d,疗程均为4周。
4) clopidogrel
氯吡格雷
1.
Improved synthesis of clopidogrel;
(+)-氯吡格雷的合成工艺改进
2.
Introduction to synthesis route of clopidogrel;
氯吡格雷的合成路线研究
3.
Effect of Clopidogrel and Asprin on Unstable Angina Pectoris in Patients;
氯吡格雷联合阿司匹林治疗不稳定型心绞痛临床观察
5) (S)-clopidogrel
(S)-氯吡格雷
1.
Preparation of methyl(R)-o-chloromandelate by asymmetric hydrogenation and transfer hydrogenation:enantioselective synthesis of the key intermediate for(S)-clopidogrel
不对称氢化、氢转移反应制备(R)-邻氯扁桃酸甲酯:(S)-氯吡格雷关键中间体的不对称合成
6) response to clopidogrel
氯吡格雷反应性
1.
The influential factors of response to clopidogrel in patients with acute coronary syndrome;
急性冠状动脉综合征患者氯吡格雷反应性的影响因素探讨
补充资料:氯吡格雷
分子式:C16H16ClNO2S
分子量:暂无
CAS号:113665-84-2
性质:暂无
制备方法:暂无
用途:抗凝血药。
分子量:暂无
CAS号:113665-84-2
性质:暂无
制备方法:暂无
用途:抗凝血药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条